Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats

Vaccine

Volumn 32, Issue 35, 2014, Pages 4529-4536

  Yamaji, Yoshiaki ^a   Nakayama, Tetsuo ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MEASLES VACCINE; PROTEIN M2; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; COTTON RAT; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEP 2 CELL LINE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INOCULATION; LUNG ALVEOLUS; LUNG HOMOGENATE; LUNG PARENCHYMA; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TEMPERATURE SENSITIVITY; VIRAL CLEARANCE; VIRUS RECOMBINANT; VIRUS STRAIN; ANIMAL; CYTOTOXICITY; DISEASE MODEL; GENETICS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG; PATHOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SECRETION (PROCESS); SIGMODONTINAE;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; LUNG; MEASLES VIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGMODONTINAE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84904392143     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.06.024     Document Type: Article

References (39)

1. Kruijsen D., Schijf M.A., Lukens M.V., van Uden N.O., Kimpen J.L., Coenjaerts F.E., et al. Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine 2011, 29:2730-2741.
2. Anderson L.J., Parker R.A., Strikas R.L. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J Infect Dis 1990, 161(4):640-646.
3. Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000, 13(3):371-384.
4. Prince G.A., Jenson a B., Hemming V.G., Murphy B.R., Walsh E.E., Horswood R.L., et al. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J Virol 1986, 57:721-728.
5. Piedra P.A., Wyde P.R., Castleman W.L., Ambrose M.W., Jewell A.M., Speelman D.J., et al. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 1993, 11:1415-1423.
6. Boukhavalova M.S., Prince G.A., Soroush L., Harrigan D.C., Vogel S.N., Blanco J.C. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine 2006, 24:5027-5035.
7. Zeng R., Qi X., Gong W., Mei X., Wei L., Ma C., et al. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2. Vaccine 2007, 25:7422-7428.
8. Hsu S.C., Shaw D.M., Steward M.W. The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope. Immunology 1995, 85:347-350.
9. Olson M.R., Hartwig S.M., Steven M., Varga S.M. The number of respiratory syncytial virus (RSV) specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. J Immunol 2008, 181:7958-7968.
10. Hussell T., Baldwin C.J., O'Garra A., Openshaw P.J. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 1997, 27:3341-3349.
11. Bueno S.M., González P.a, Cautivo K.M., Mora J.E., Leiva E.D., Tobar H.E., et al. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Nat Acad Sci USA 2008, 105:20822-20827.
12. Rutigliano J.A., Rock M.T., Johnson A.K., Crowe J.E., Graham B.S. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 2005, 337:335-343.
13. Hsu S.C., Chargelegue D., Steward M.W. Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide. Virology 1998, 240:376-381.
14. + T-cell memory in the respiratory tract. Nat Med 2002, 8:54-60.
15. + T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope. Peptides 2008, 26:4775-4782.
16. Reimers K., Buchholz K., Werchau H. Respiratory syncytial virus M2-1 protein induces the activation of nuclear factor kappa B. Virology 2005, 331:260-268.
17. Tregoning J.S., Wang B.L., McDonald J.U., Yamaguchi Y., Harker J.A., Goritzka M., et al. Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection. Proc Nat Acad Sci USA 2013, 110:5576-5581.
18. Heidema J., de Bree G.J., De Graaff P.M., van Maren W.W.C., Hoogerhout P., Out T., et al. Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J Gen Virol 2004, 85:2365-2374.
19. Shao H.-Y., Lin Y.-W., Yu S.-L., Lin H.-Y., Chitra E., Chang Y.-C., et al. Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse. PLoS One 2011, 6:e25500.
20. Sawada A., Komase K., Nakayama T. AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats. Vaccine 2011, 29:1481-1490.
21. Cherrie A.H., Anderson K., Wertz G.W., Openshaw P.J. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J Virol 1992, 66:2102-2110.
22. Mckimm-breschkin J.L. Short communication A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. J Virol Methods 2004, 120:113-117.
23. Tran T.-L., Castagné N., Dubosclard V., Noinville S., Koch E., Moudjou M., et al. The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol 2009, 83:6363-6374.
24. Simões E.a.F., Carbonell-Estrany X., Rieger C.H.L., Mitchell I., Fredrick L., Groothuis J.R. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010, 126:256-262.
25. Ramaswamy M., Shi L., Varga S.M., Barik S., Behlke M.A., Look D.C. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006, 344:328-339.
26. Kruijsen D., Einarsdottir H.K., Schijf M.A., Coenjaerts F.E., van der Schoot E.C., Vidarsson G., et al. Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice. J Virol 2013, 87:7550-7557.
27. Schmueck M., Fischer A.M., Hammoud B., Brestrich G., Fuehrer H., Luu S.-H., et al. Preferential expansion of human virus-specific multifunctional central memory T cells by partial targeting of the IL-2 receptor signaling pathway: the key role of CD4+ T cells. J Immunol 2012, 188:5189-5198.
28. Stevens W.W., Sun J., Castillo J.P., Braciale T.J. Pulmonary eosinophilia is attenuated by early responding CD8{thorn} memory T cells in a murine model of RSV vaccine-enhanced disease. Viral Immunol 2009, 22:243-251.
29. Kulkarni A.B., Collins P.L., Bacik I., Yewdell J.W., Bennink J.R., Crowe J.E., et al. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol 1995, 69:1261-1264.
30. De Baets S., Schepens B., Sedeyn K., Schotsaert M., Roose K., Bogaert P., et al. Recombinant influenza virus carrying the respiratory syncytial virus F85-93 CTL epitope reduces RSV replication in mice. J Virol 2013, 87:3314-3323.
31. Shaw C.A., Galarneau J.-R., Bowenkamp K.E., Swanson K.A., Palmer G.A., Palladino G., et al. The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease. Vaccine 2013, 31:306-312.
32. + T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology 2006, 352:157-168.
33. Murata Y., Lightfoote P.M., Biear J.N., Falsey A.R., Walsh E.E. Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein. Vaccine 2010, 28:6242-6246.
34. Swanson K.A., Settembre E.C., Shaw C.A., Dey A.K., Rappuoli R., Mandl C.W., et al. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Nat Acad Sci USA 2011, 108:9619-9624.
35. Van Bleek G.M., Poelen M.C., Van Der Most R., Brugghe H.F., Timmermans H.A., Boog C.J., et al. Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J Virol 2003, 77:980-988.
36. Cherukuri A., Stokes K.L., Patton K., Kuo H., Sakamoto K., Lambert S., et al. An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice. Immun Ageing 2012, 9:21.
37. Fan C.-F., Zeng R.-H., Sun C.-Y., Mei X.-G., Wang Y.-F., Liu Y. Fusion of DsbA to the N-terminus of CTL chimeric epitope F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice. Vaccine 2005, 23:2869-2875.
38. Ruckwardt T.J., Luongo C., Malloy A.M.W., Liu J., Chen M., Collins P.L., et al. Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. J Immunol 2010, 185:4673-4680.
39. Olson M.R., Varga S.M. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J Immunol 2007, 179:5415-5424.